The use of nuclear scintigraphy to evaluate the anabolic effects of teriparatide on the skeleton in postmenopausal women with osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2010
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2007 Status changed from recruiting.
- 31 Mar 2006 New trial record.